Cholesterol biosynthesis in cancer is known to be regulated by PI3K/AKT/mTOR, RTK/RAS, and mutated p53 through SREBP activation by mechanisms that have been previously reviewed [160,161]. The gene discussed is TP53; the disease is cancer.